Dr Shashank Sharma


MBBS, DTCD, PgCert Heath and Biomedical Education, MRCP (Respiratory), FRCP (Medicine)

GMC number: 6072505

Practising since: MBBS 2001, CCST 2014.


Respiratory Medicine

Consultation times

  • Fridays


Dr Sharma is a Respiratory consultant specialising in all areas of adult Respiratory pathologies at Ashford and St. Peter’s Hospitals NHS Foundation Trust. Dr Sharma has led the development of Sleep services, TB, Interstitial Lung Disease, and Pleural diseases. Dr Sharma’s subspeciality interests include Lung cancer, Airways disease and Respiratory infections.

As Respiratory clinical lead, Dr Sharma led the development of Respiratory services to Covid-19 pandemic. Dr Sharma has developed pleural services at ASPH with the commencement of Medical Thoracoscopy services allowing specialist cancer treatment locally. He also developed ILD services and regularly runs virtual ILD MDT with Royal Brompton Hospital to bring specialist travel near to patients’ home.

Special interests

Chronic Intractable Cough ; Long Covid, Breathlessness; Asthma; COPD; Bronchiectasis; Pulmonary Fibrosis; Lung cancer; Bronchoscopy, EBUS and Medical Thoracoscopy; Sleep apnoea; TB; Pneumonia and recurrent chest infections; Pleural effusion.

Other interests

Breathlessness of unknown cause.

Personal interests

Tennis, Yoga/Meditation, Walking.

Languages spoken

English, Hindi, Urdu, Punjabi, Tamil

Locations Dr Shashank Sharma works with

Related experience


❖ Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial’. BMJ Open 2023;13:e068179. doi:10.1136/bmjopen-2022-068179 Ines Kralj-Hans, Kuo Li, Adrian Wesek, Alexia Lamorgese, Fatima Omar, Kapila Ranasinghe, Megan McGee, Kieran Brack, Shiliang Li, Ritesh Aggarwal, Ajay Bulle, Aparna Kodre, Shashank Sharma, David Fluck, Isaac John, Pankaj Sharma, Jonathan D Belsey, Ling Li, Sreenivasa Rao Kondapally Seshasai, Hong Lin Li, Nandor Marczin, Zhong Chen

❖ ‘Chest radiographs may assist in predicting the outcome in the early phase of Covid-19. UK district general hospital experience of Covid-19 first wave’. Expert Review of Respiratory Medicine Volume 15, 2021 - Issue 4 Max Berrill,Jola Karaj,Georgiana Zamfir,Jordan Colman,Rachel Mason,Saeed Akbar,Shashank Sharma,Frances Sheehan,Kanchan Dhamija,Felicity Saltissi,Aigul Baltabaeva &Sujoy Saikia

❖ ‘A novel ambulatory management pathway for Cobid-19 patients using home oximetry’. European Respiratory Journal 2021 58: PA3673; DOI: 10.1183/13993003.congress-2021.PA3673 Shashank Sharma, Sujoy Saikia, Ali Fawzi, Sriram Thillainayagam, C Wade, Frederick Tibbs, Elise Spiers, Jola Karaj

❖ ‘The role of CT Thorax scans in triaging suspected cases of Covid-19’. European Respiratory Journal 2021 58: PA3246; DOI: 10.1183/13993003.congress-2021.PA3246 Mary Flynn, Hyun Park, K Aguilaresguerra, A Fawzi, S Saikia, A Chapman, S Sharma

❖ ‘Pembrolizumab-induced subacute sensory ataxia’. VOLUME 115, SUPPLEMENT 1, S8-S9, JANUARY 2018. DOI:https://doi.org/10.1016/S0169-5002(18)30045-X A.J.S. Furness, J. Coebergh, M. Wood, M. Irvine-Sellars, S. Saikia, S. Sharma, B. McBride, C. Johnson, M. Teoh, F. Cockroft, S. Wing, P. Murray, M. Hewish

❖ Oxygen desaturation index for diagnosing obstructive sleep apnoea in patients with morbid obesity December 2017, Thorax 72(Suppl 3):A115-A115, DOI: 10.1136/thoraxjnl-2017-210983.204 A Fawzi, Hussain Helal Basheer, M Patel, S Sharma

❖ ‘Stroke due to thromboembolism from congenital aneurysm of ventricular septum’. Acute Med. 2008; 7(1): 43-4. S.Sharma, A Thomas, A. Baghomian, N. Waterfield. Published in Acute Medicine (Volume 7 Issue 1, 2008).

❖ A comparative evaluation of the efficacy of inhaled Beclomethasone dipropionate, Budesonide and Fluticasone propionate in the management of Bronchial Asthma’. U Parikh, K.Gupta,


  • Royal College of Physicians
  • Medical Protection Society

Other posts held

  • Ashford and St. Peter’s Hospitals NHS Foundation Trust


Dr Shashank Sharma does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Shashank Sharma does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Shashank Sharma does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.